| Literature DB >> 28666441 |
Petra Um-Bergström1,2,3, Jenny Hallberg4,5, Per Thunqvist4,6, Eva Berggren-Broström4,6, Martin Anderson7,8, Gunilla Adenfelt4, Gunnar Lilja4,6, Giovanni Ferrara9,10, C Magnus Sköld9,10, Erik Melén4,5,11.
Abstract
BACKGROUND: Bronchopulmonary dysplasia (BPD) is a strong risk factor for respiratory morbidity in children born preterm. Our aims were to evaluate lung function in adolescents born preterm with and without a history of BPD, and to assess lung function change over time from school age.Entities:
Keywords: Adolescents; Bronchopulmonary dysplasia; Ergospirometry; Lung function tests; Oscillometry; Spirometry
Mesh:
Year: 2017 PMID: 28666441 PMCID: PMC5493015 DOI: 10.1186/s12890-017-0441-3
Source DB: PubMed Journal: BMC Pulm Med ISSN: 1471-2466 Impact factor: 3.317
Fig. 1Schematic description of the patient cohort. Abbreviations: BPD = Bronchopulmonary Dysplasia; IOS = Impulse Oscillometry; m = male; f = female
Perinatal characteristics of study participants born preterm, by BPD severity
| Mild BPD | Moderate BPD | Severe BPD | All BPD | Non-BPD |
| |
|---|---|---|---|---|---|---|
|
|
|
|
|
| (All vs Non BPD) | |
| Gestational age at birth, weeks | 27 (24–30) | 28 (25–30) | 28 (25–29) | 27 (24–30) | 30 (28–31) | <0.001 |
| Birth weight, g | 995 (654–1520) | 1145 (597–1252) | 905 (775–1210) | 1003 (597–1520) | 1425 (845–2094) | 0.001 |
| Male sex | 12 (71%) | 6 (86%) | 2 (50%) | 21 (75%) | 12 (52%) | 0.51 |
| Instillation of surfactant | 1 (5.9%) | 3 (43%) | 2 (50%) | 6 (21%) | 1 (4.3%) | 0.24 |
| Ventilation therapy, days | 0 (0–34) | 4 (0–38) | 23 (0–33) | 1 (0–38) | 0 (0–5) | 0.003 |
| CPAP, days | 31 (4–70) | 32 (3–55) | 38.5 (13–60) | 32 (3–70) | 4 (0–18) | <0.001 |
| Supplemental O2, days | 54 (27–83) | 72 (28–96) | 141 (105–180) | 62 (27–180) | 3 (0–26) | <0.001 |
| Maternal smoking during pregnancy | 2 (12%) | 2 (29%) | 4 (100%) | 8 (29%) | 6 (26%) | 0.06 |
| Prenatal corticosteroid therapy | 10 (60%) | 4 (57%) | 2 (50%) | 16 (57%) | 15 (65%) | 0.96 |
| Septicemia | 9 (53%) | 4 (57%) | 3 (75%) | 16 (57%) | 4 (17%) | 0.22 |
| PDA | 9 (53%) | 5 (71%) | 2 (50%) | 16 (57%) | 7 (30%) | 0.36 |
| ROP grade 3–4 | 5 (29%) | 3 (43%) | 2 (50%) | 10 (36%) | 1 (4.3%) | 0.007 |
Abbreviations: BPD Bronchopulmonary dysplasia, CPAP continuous positive airway pressure, PDA patent ductus arteriosus, ROP retinopathy of prematurity
Data are presented as median (range) or numbers (%)
Expiratory flows and volumes in z-scores in school children and adolescents with and without history of BPD
| Mild BPD | Moderate BPD | Severe BPD | All BPD | Non-BPD | P trend | |
|---|---|---|---|---|---|---|
|
|
|
|
|
| ||
| Spirometry at 6–8 years | ||||||
| FEV1
| −1.10** (−1.63;-0.12) | −0.63* (−1.38;-0.41) | −2.63** (−3.56;-2.33) | −1.35 *** (−2.11;-0.41) | −0.13 (−0.51;-0.58) | <0.001 |
| FVC | −1.09** (−1.50;-0.12) | −0.54 (−0.62;-0.02) | −2.21** (−2.92;-1.50) | −0.82*** (−1.50;0.03) | 0.22 (1.18;0.70) | 0.001 |
| FEV1/FVC | −0.05 (−1.02;0.90) | −0.26 (−2.03;0.05) | −1.90* (−2.34;-1.04) | −0.26 (−1.70;-0.16) | −0.03 (−1.23;0.59) | 0.022 |
| Spirometry at13–17 years | ||||||
| FEV1
| −0.40 (−1.48;-0.10) | −0.62 (−2.03;0.38) | −2.43** (−2.95;-2.14) | −0.61* (−2.04;0.07) | −0.02 (−0.37;0.55) | 0.002 |
| FVC | −0.31 (−0.96;0.28) | 0.29 (0.00;1.63) | - 0.77* (−1.28;-0.33) | - 0.18 (−0.85;0.28) | 0.35 (−0.43;0.66) | 0.175 |
| FEV1/FVC | −0.18 (−0.94;0.12) | −1.04 (−2.80;-0.22) | −2.95** (−3.20;-2.17) | −0.82* (−2.57;-0.10) | −0.47 (−1.09;0.58) | 0.001 |
Comparing between non-BPD and BPD groups using the Wilcoxon rank-sum test. P * ≤0.05, ** ≤ 0.01, *** ≤0.001. P-values for trend using nonparametric test for trend across ordered groups. Trend test comparing Non-BPD vs mild, moderate, and severe BPD
Data expressed as median (25th and 75th centiles)
Difference in adjusted medians of lung function when comparing BPD groups to “no BPD”
| Mild BPD | Moderate BPD | Severe BPD | All BPD | Non-BPD | P trend | |
|---|---|---|---|---|---|---|
| Static spirometrya |
|
|
|
|
| |
| TLC (mL) | −464 (−1151;224) | 345 (−460;1150) | 18 (−938;974) | −373 (−932;186) | Ref | 0.848 |
| RV (mL) | −148 (−536;240) | −147 (−602;307) | 215 (−325;754) | −100 (−360;160) | Ref | 0.773 |
| Impulse oscillometrya |
|
|
|
|
| |
| R5–20 (kPa/L/s) | 0.036 (−0.019;0.090) | 0.013 (−0.069;0.095) | 0.340*** (0.218;0.461) | 0.041 (−0.010;0.093) | Ref | 0.029 |
| AX (kPa/L) | 0.034 (−0.322;0.38) | 0.134 (−0.403;0.670) | 3.704*** (2.907;4.502) | 0.115 (−0.187;0.418) | Ref | 0.275 |
| Ergospirometryb |
|
|
|
|
| |
| VO2 (mL/kg/min) | −1.7 (−9.3;5.9) | −2.3 (−11.8;7.2) | −9.1 (−20.5;2.3) | −4.0 (−10.9;2.9) | Ref | 0.069 |
aAnalysis with linear regression on the median adjusting for age, sex and height. bAnalysis with linear regression on the median adjusting for sex. Trend test comparing Non-BPD vs mild, moderate, and severe BPD
Comparing between non-BPD and BPD groups including all BPD using (a) and (b). P * ≤0.05, ** ≤ 0.01, *** ≤0.001
Data presented as difference (95% CI)
Fig. 2Z-scores presented as median (25th and 75th centiles) for FVC, FEV1 and FEV1/FVC at 7 and 14 years of age in children with no, mild, moderate, severe and all BPD. P-values for comparison of the change from 7 to 14 years in mild, moderate and severe BPD groups compared to the non-BPD group. Nonparametric test for trend across ordered groups comparing mild, moderate and severe BPD to the non-BPD group. P * ≤0.05, ** ≤ 0.01, *** ≤0.001